HSE has conducted a review of the approval of the active substance indoxacarb and proposes to withdraw the approval. HSE reviewed the approval of indoxacarb in light of new scientific information which indicated that the active substance may no longer satisfy the criteria for approval. The review considered the effect on the risk assessment of new toxicological reference values for this active substance, alongside comments provided by producers and authorisation holders. In particular, it was found that non-dietary exposure for various representative uses was above acceptable limits for operators, workers, residents, and bystanders. HSE therefore proposes to withdraw approval of indoxacarb in Great Britain (GB). Details of this proposal will now be forwarded to the World Trade Organisation for consultation with trading partners. Further information and developments relating to the approval of indoxacarb will be recorded in the statutory approvals register of active substances. In October 2021 the EU adopted revision 11 of the PPP guidance on the relevance assessment of groundwater metabolites. Revision 11 updates the existing EU SANCO guidance (rev 10) from 2003. The revisions are minor and apply only to the toxicology area of the assessment. References to hazard classification have been updated to reflect the entry into force of the CLP Regulation in 2008. While GB accepts the translation of the hazard classification system, GB does not agree with the changes introduced in the area of genotoxicity testing. On this basis, GB proposes that the updated EU guidance is adopted in GB but with amendments to the genotoxicity testing requirements. These new testing requirements will be implemented for new applications no later than 6 months from the publication of this ebulletin or earlier if applicants decide to do so. View the updated guidance and GB testing requirements on our Pesticides website. If you have any questions relating to this ebulletin, please contact us. | 
No comments:
Post a Comment